Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Anticancer Drugs
1.2 Key Market Segments
1.2.1 Anticancer Drugs Segment by Type
1.2.2 Anticancer Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Anticancer Drugs Market Overview
2.1 Global Market Overview
2.1.1 Global Anticancer Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Anticancer Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Anticancer Drugs Market Competitive Landscape
3.1 Global Anticancer Drugs Sales by Manufacturers (2019-2024)
3.2 Global Anticancer Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Anticancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Anticancer Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Anticancer Drugs Sales Sites, Area Served, Product Type
3.6 Anticancer Drugs Market Competitive Situation and Trends
3.6.1 Anticancer Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Anticancer Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Anticancer Drugs Industry Chain Analysis
4.1 Anticancer Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Anticancer Drugs Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Anticancer Drugs Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Anticancer Drugs Sales Market Share by Type (2019-2024)
6.3 Global Anticancer Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Anticancer Drugs Price by Type (2019-2024)
7 Anticancer Drugs Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Anticancer Drugs Market Sales by Application (2019-2024)
7.3 Global Anticancer Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Anticancer Drugs Sales Growth Rate by Application (2019-2024)
8 Anticancer Drugs Market Segmentation by Region
8.1 Global Anticancer Drugs Sales by Region
8.1.1 Global Anticancer Drugs Sales by Region
8.1.2 Global Anticancer Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Anticancer Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Anticancer Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Anticancer Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Anticancer Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Anticancer Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 F. Hoffmann-La Roche Ltd
9.1.1 F. Hoffmann-La Roche Ltd Anticancer Drugs Basic Information
9.1.2 F. Hoffmann-La Roche Ltd Anticancer Drugs Product Overview
9.1.3 F. Hoffmann-La Roche Ltd Anticancer Drugs Product Market Performance
9.1.4 F. Hoffmann-La Roche Ltd Business Overview
9.1.5 F. Hoffmann-La Roche Ltd Anticancer Drugs SWOT Analysis
9.1.6 F. Hoffmann-La Roche Ltd Recent Developments
9.2 Eli Lilly and Company
9.2.1 Eli Lilly and Company Anticancer Drugs Basic Information
9.2.2 Eli Lilly and Company Anticancer Drugs Product Overview
9.2.3 Eli Lilly and Company Anticancer Drugs Product Market Performance
9.2.4 Eli Lilly and Company Business Overview
9.2.5 Eli Lilly and Company Anticancer Drugs SWOT Analysis
9.2.6 Eli Lilly and Company Recent Developments
9.3 CELGENE CORPORATION
9.3.1 CELGENE CORPORATION Anticancer Drugs Basic Information
9.3.2 CELGENE CORPORATION Anticancer Drugs Product Overview
9.3.3 CELGENE CORPORATION Anticancer Drugs Product Market Performance
9.3.4 CELGENE CORPORATION Anticancer Drugs SWOT Analysis
9.3.5 CELGENE CORPORATION Business Overview
9.3.6 CELGENE CORPORATION Recent Developments
9.4 Novartis AG
9.4.1 Novartis AG Anticancer Drugs Basic Information
9.4.2 Novartis AG Anticancer Drugs Product Overview
9.4.3 Novartis AG Anticancer Drugs Product Market Performance
9.4.4 Novartis AG Business Overview
9.4.5 Novartis AG Recent Developments
9.5 Pfizer Inc
9.5.1 Pfizer Inc Anticancer Drugs Basic Information
9.5.2 Pfizer Inc Anticancer Drugs Product Overview
9.5.3 Pfizer Inc Anticancer Drugs Product Market Performance
9.5.4 Pfizer Inc Business Overview
9.5.5 Pfizer Inc Recent Developments
9.6 Amgen Inc
9.6.1 Amgen Inc Anticancer Drugs Basic Information
9.6.2 Amgen Inc Anticancer Drugs Product Overview
9.6.3 Amgen Inc Anticancer Drugs Product Market Performance
9.6.4 Amgen Inc Business Overview
9.6.5 Amgen Inc Recent Developments
9.7 Bayer AG
9.7.1 Bayer AG Anticancer Drugs Basic Information
9.7.2 Bayer AG Anticancer Drugs Product Overview
9.7.3 Bayer AG Anticancer Drugs Product Market Performance
9.7.4 Bayer AG Business Overview
9.7.5 Bayer AG Recent Developments
9.8 AstraZeneca
9.8.1 AstraZeneca Anticancer Drugs Basic Information
9.8.2 AstraZeneca Anticancer Drugs Product Overview
9.8.3 AstraZeneca Anticancer Drugs Product Market Performance
9.8.4 AstraZeneca Business Overview
9.8.5 AstraZeneca Recent Developments
9.9 Takeda Pharmaceutical Company Limited
9.9.1 Takeda Pharmaceutical Company Limited Anticancer Drugs Basic Information
9.9.2 Takeda Pharmaceutical Company Limited Anticancer Drugs Product Overview
9.9.3 Takeda Pharmaceutical Company Limited Anticancer Drugs Product Market Performance
9.9.4 Takeda Pharmaceutical Company Limited Business Overview
9.9.5 Takeda Pharmaceutical Company Limited Recent Developments
9.10 Merck and Co.
9.10.1 Merck and Co. Anticancer Drugs Basic Information
9.10.2 Merck and Co. Anticancer Drugs Product Overview
9.10.3 Merck and Co. Anticancer Drugs Product Market Performance
9.10.4 Merck and Co. Business Overview
9.10.5 Merck and Co. Recent Developments
10 Anticancer Drugs Market Forecast by Region
10.1 Global Anticancer Drugs Market Size Forecast
10.2 Global Anticancer Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Anticancer Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Anticancer Drugs Market Size Forecast by Region
10.2.4 South America Anticancer Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Anticancer Drugs by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Anticancer Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Anticancer Drugs by Type (2025-2030)
11.1.2 Global Anticancer Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Anticancer Drugs by Type (2025-2030)
11.2 Global Anticancer Drugs Market Forecast by Application (2025-2030)
11.2.1 Global Anticancer Drugs Sales (Kilotons) Forecast by Application
11.2.2 Global Anticancer Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
